Hematuria epidemiology and demographics

Hematuria Microchapters
Home
Patient Information
Overview
Definition
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hematuria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hematuria epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hematuria epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hematuria epidemiology and demographics
CDC on Hematuria epidemiology and demographics
Hematuria epidemiology and demographics in the news
Blogs on Hematuria epidemiology and demographics
Directions to Hospitals Treating Hematuria
Risk calculators and risk factors for Hematuria epidemiology and demographics

Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]

Overview

Asymptomatic hematuria is common in clinical practice, with a prevalence ranging from 0.18% to 38.7%.

Age

Young patients are more likely to have intrinsic renal pathology (i.e. glomerulonephritis whereas malignancy is more common in the elderly).

Sex

Malignancy of the bladder and kidney is at least twice as common in males than in females. Women are more commonly affected by urinary tract infections.